These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16786906)

  • 41. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction.
    Galve E; Mallol A; Catalan R; Palet J; Méndez S; Nieto E; Diaz A; Soler-Soler J
    Eur J Heart Fail; 2005 Aug; 7(5):892-8. PubMed ID: 16087141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diuretic usage in heart failure: a continuing conundrum in 2005.
    Gupta S; Neyses L
    Eur Heart J; 2005 Apr; 26(7):644-9. PubMed ID: 15734765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Volume retention in heart failure, nephrotic syndrome, and liver cirrhosis].
    Heine GH; Sester U; Köhler H
    Internist (Berl); 2006 Nov; 47(11):1136, 1138-40, 1142-44. PubMed ID: 17009041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current acquisitions in diuresis and diuretic therapy].
    Varese LA
    Minerva Pediatr; 1970 Oct; 22(41):1985-96. PubMed ID: 4924425
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanisms and management of diuretic resistance in congestive heart failure.
    De Bruyne LK
    Postgrad Med J; 2003 May; 79(931):268-71. PubMed ID: 12782772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Edema formation in congestive heart failure and the underlying mechanisms.
    Abassi Z; Khoury EE; Karram T; Aronson D
    Front Cardiovasc Med; 2022; 9():933215. PubMed ID: 36237903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
    Hasenfuss G; Holubarsch C; Herzog C; Knauf H; Spahn H; Mutschler E; Just H
    Clin Cardiol; 1987 Feb; 10(2):83-8. PubMed ID: 3815928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body fluid volume regulation in health and disease.
    Abraham WT; Schrier RW
    Adv Intern Med; 1994; 39():23-47. PubMed ID: 8140955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diuretic Resistance in Cardio-Nephrology: Role of Pharmacokinetics, Hypochloremia, and Kidney Remodeling.
    Masella C; Viggiano D; Molfino I; Zacchia M; Capolongo G; Anastasio P; Simeoni M
    Kidney Blood Press Res; 2019; 44(5):915-927. PubMed ID: 31437845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diuretic drug therapy of edema.
    Perez-Stable EC; Materson BJ
    Med Clin North Am; 1971 Mar; 55(2):359-72. PubMed ID: 4926056
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diuretic-resistant edema].
    Shiikai T; Ideura T; Matsui N; Koshikawa S
    Nihon Rinsho; 1974 Aug; 32(8):2619-28. PubMed ID: 4612208
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacological Properties of Loop Diuretics and Their Clinical Effects].
    Sakalauskienė G; Civinskienė G; Antuševas A; Civinskas P
    Kardiologiia; 2018 Jan; (1):72-83. PubMed ID: 29466174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Optimization of diuretic therapy in heart failure].
    Knauf H; Hasenfuss G; Just HJ
    Verh Dtsch Ges Inn Med; 1985; 91():155-67. PubMed ID: 4090614
    [No Abstract]   [Full Text] [Related]  

  • 57. The rational use of diuretics in heart failure.
    Ravnan SL; Deedwania PC
    Curr Cardiol Rep; 2003 May; 5(3):237-42. PubMed ID: 12691643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.
    ter Maaten JM; Valente MA; Damman K; Hillege HL; Navis G; Voors AA
    Nat Rev Cardiol; 2015 Mar; 12(3):184-92. PubMed ID: 25560378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Progress in management for heart failure: diuretics].
    Aoyagi T; Hirata Y
    Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.